Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer

Figure 5

DEK expression is related to irinotecan response and correlates with poor outcome in KRAS wt patients. A) Representative IHC images for low, medium or high staining intensities of DEK expression levels. B) Kaplan-Meier plot shows a significant association between high DEK level and lower progression-free survival after irinotecan-based treatment in KRAS wt patients (P = 0.010).

Back to article page
\